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ABSTRACT: The coronavirus disease 2019 (COVID-19) pandemic has a significant impact on the public 
mental problem. The anxiety and depression symptoms are a common emotional reaction to the COVID-
19 pandemic. The objective of the study was to assess the level of depression and anxiety reactions and 
associated factors among COVID-19 patients at the COVID-19 center of the Armed Force Comprehensive 
Hospital in Ethiopia. Across-sectional study was conducted among 150 COVID-19 patients who were 
interviewed for the survey in the Afaan Oromo language. The Beck’s Depression Inventory and Beck’s 
Anxiety Inventory measuring scale questionnaires were adapted and used to measure depression and 
anxiety of COVID-19 patients. Data were analyzed by logistic regression using SPSS computer software 
version 23. Mean age of the COVID-19 patients was 29 with a standard deviation of ± 7.6 years. Among 
the total respondents, 92 (61.3%) were males. The overall prevalence of depression from borderline 
clinical to severe was 84% and anxiety from moderate to severe was 86.7%. The multivariate regression 
analysis showed that being married, divorced, fear of death, poor sleep quality, fear of re-infection, less 
family support, loneliness, and lower oxygen saturation were positively associated with depression and 
anxiety reactions. From study participants, the majority of them were presented with features of 
depression and anxiety. Being married, divorced, fear of death, poor sleep quality, fear of re-infection, 
less family support, loneliness, and lower oxygen saturation were the associated factors with 
depression and anxiety reaction for COVID-19 patients.  
 





Coronavirus disease 2019 (COVID-19) is first 
recognized in Wuhan, Hubei Province of China 
since December 2019, which is a worldwide 
pandemic of public health emergency and has 
features spreading rapidly around the globe 
(Chinazzi et al., 2020; Nishiura et al., 2020; Zhou et 
al., 2020). By August 31, 2020, the World Health 
Organization (WHO) reported that more than 41 
million were infected 1,130,220 deathsglobally, 
1,675,580 infections and 40,309 deaths in African, 
and 90,490 cases and 1,371 deaths in Ethiopia 
which is increasing from day to day (WHO, 2020). 
Anxiety and depression are common mental 
illnesses in the world and the most impact causing 
mental problems. During this outbreak, the mental 
health issue is not an ignored problem since there 
is the influence of the outbreak on the mental 
health problem. As different studies revealed that 
depression and anxiety are commonly persistent 
among chronic diseases. Symptoms of depression 
and anxiety are common psychological reactions to 
COVID-19 (Dai et al., 2020; Hopwood & Stephens, 
2000; Natale et al., 2019; Pathan & Thakur, 2020; 
Polikandrioti et al., 2015; WHO, 2017). 
 As different studies indicated that among 
COVID-19 patients surveyed, a significant 
proportion was experiencing mental illnesses; 
mainly depression and anxiety that cause trouble 
of symptom regulator and have decreased quality 
of life. Though recently published researches on 
the psychological impact of COVID-19 are mainly 
focused on the healthcare workers despite, the 
general public who were worried about the risks of 
infection and protective measures, resulting in 
psychological distress (Dai, Hu, Xiong, Qiu, & 
Yuan, 2020; Wang et al., 2020; Zhu et al., 2020). 
 Even though COVID-19 is a new strain of 
coronaviruses, it is known by causing diseases 
ranging from cold to more severe illnesses like 
Middle East Respiratory Syndrome (MERS) and 
Severe Acute Respiratory Syndrome (SARS). Severe 
cases of this disease can lead to cardiac problems 
like heart failure, and respiratory syndrome, and 
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renal failure as well as death. Anxiety is one of the 
common psychosocial problems that affect the 
majority of populations. Many of the current 
research evidence suggests that isolated and 
quarantined people were experiencing a significant 
level of anxiety, stress, and confusion (Ashour, 
Elkhatib, Rahman, & Elshabrawy, 2020; Brooks et 
al., 2020; Holshue et al., 2020). 
As different strategies were implemented by 
different countries in the world to minimize the 
risk of the COVID-19 transmission in the 
community. Ethiopia also declared an emergency 
state to minimize the risk of COVID-19 transmission 
by applying travel restrictions, physical distancing, 
quarantine, frequent handwashing, reducing the 
capacity of public transportation, and stay-at-home 
preventive and control strategies. Despite many 
efforts to reduce the risk of COVID-19 transmission, 
mental health problems and psychological impact 
among COVID-19 patients have remained high. 
Therefore, this study aimed to assess the level of 
depression, anxiety, and associated factors among 
COVID-19 patients in the COVID-19 center of an 
Armed Force Comprehensive Hospital in Ethiopia.  
 
 
METHODS AND MATERIALS 
 
Study Design, Setting, and Population  
The institution-based cross-sectional study was 
conducted from 15 July to 30 August 2020 at 
COVID-19 Center of Armed Force Comprehensive 
Hospital in Ethiopia. The COVID-19 center of 
Armed Force Comprehensive Hospital is found in 
Oromia regional state in Bishoftu town which is 
about 40 kilometers far from Addis Ababa (the 
capital city of Ethiopia) to the Northeast. The 
hospital gives service for 600 SARS Cov-2 positive 
patients. All SARS Cov-2 positive (18 years or older) 
and admitted patients were included, except those 
who were critically ill and unable to talk at the 
time of data collection. Samples of 150 COVID-19 
patients were selected by simple random sampling 
techniques.  
 The data were collected by three nurses holding 
a Bachelor of Science degree under the supervision 
of a senior psychiatry professional. The data 
collectors were provided one day of concentrated 
training on the content of the measuring tool and 
how to select a participant for the interview. The 
principal investigators also made a continuous 
follow-up to ensure the quality of the data 
collected. The Institutional Review Board of the 
College of Health Sciences at Defense University 
had reviewed and approved the research project 
and a letter of cooperation was written to COVID-19 
Center of Armed Force Comprehensive Hospital. 
After permission was obtained from the authorities 
of the study setting, the written informed consents 
were secured from each participant and the study 
was conducted as per the Declaration of Helsinki. 
 
Measurements 
The socio-demographic characteristics and other 
factors for COVID-19 patients were recorded using 
14-items. These include sex, age, religion, 
educational status, occupation, marital status, fear 
of death, stigma, absence of sleep, fear of re-
infection, less social support, loneliness, economic 
impact, and lower oxygen saturation. The 
measurements for depression and anxiety 
concerning COVID-19 positive patients were 
recorded using 21-items Beck Depression 
Inventory and 21-items Beck Anxiety Inventory.  
Both the Beck Depression Inventory (BDI) and 
Beck Anxiety Inventory (BAI) were used to 
measure depression and anxiety reactions of the 
COVID-19 patients, respectively. Both tools contain 
21 items with a Likert scale ranging from 0 (not at 
all) to 3 (severely). The total score (0-63) was 
obtained by summing up the scores of all items. 
The cut-off point for levels of depression 
interpretation was >17 score points without 
focusing on normal mood (1-10) and mild mood 
disturbance (11-16) scores. Borderline clinical 
depression (17-20), moderate depression (21-30), 
severe depression (31-40), and extreme depression 
(>40) scores were considered for the level of 
depression assessment. Again, for the level of 
anxiety interpretation, the cut-off point for 
individuals with anxiety problems was > 22-point 
scores without emphasizing a mild form of anxiety 
reaction because it is the usual problem without 
causing significant clinical distress, occupational, 
and functional impairment. The moderate form of 
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anxiety with a grand sum between 22-35 score and 
the severe form of anxiety with a grand sum of > 
36 scores was considered potentially concerning 
levels of anxiety for assessment (Beck, Epstein, 
Brown, Steer, & psychology, 1988; Sprinkle et al., 
2002). 
Data was collected in the Afaan Oromo language 
using a face-to-face interviewer. In this regard, the 
questionnaire was translated from English to the 
Afaan Oromo language by a fluent translator and 
then back-translated to English by another fluent 
translator. Before data collection, we assessed the 
Afaan Oromo language version of the BDI and BAI 
to ensure meaning equivalence with the original 
English. 
 
Data Processing and Analysis 
Data were coded, entered, and cleaned using 
Epi-data version 3.1 and then transferred to SPSS 
version 23.0 for analysis. Frequency distributions 
were computed for sociodemographic variables 
and the patient’s reactions. The independent 
variables in this study were sociodemographic 
factors and the dependent variables were 
depression and anxiety. The independent variables 
associations with depression and anxiety reactions 
were analyzed first by using bivariate analysis. 
Then, only those variables with p-values < 0.25 
were taken as a candidate for multivariate logistic 
analysis. In the multivariate logistic analysis p-






Sociodemographic Characteristics of the 
Participants 
All of the study participants (150) were 
interviewed with a 100% response rate. The age of 
respondents ranges from 18 to 60 years with the 
mean age of 29 ± 7.6 years. Among the total 
respondents, 92 (61.3%) were males, 77 (51.3%) 
were married and 71 (47.3%) were Christian by 
religion. Half (50%) of them have attended 
College/University education and 76 (50.6%) were 
military members(Table 1). 
 
Table 1. Distribution of participants by socio-
demographic characteristics of COVID-19 
patients at Armed Force Comprehensive 
Hospital in Oromia, Ethiopia (n=150). 
 




Sex  Male  92 61.3 
Female  58 38.7 
Age  18-22 11 7.3 
23-27 40 26.7 
28-32 53 35.3 
> 33 16 10.7 
Religion  Orthodox  71 47.3 
Muslim  29 19.3 
Protestant  42 28 
Others  8 5.3 
Educational 
status  
Primary school 35 23.3 
High school 40 26.7 
College/University 75 50 
Occupation  Jobless  5 3.3 
Civilian workers  69 46 
Military  76 50.7 
Marital status  Single  53 35.3 
Married  77 71.3 
Divorce  20 13.3 
 
Factors that contribute to the presence of anxiety 
and depression among COVID-19 patients at the 
Armed Force Comprehensive COVID-19 center 
Hospital. 
Among the factors that contribute to 
depression and anxiety for COVID-19 patients, fear 
of death (96.7%), lower oxygen saturation (93.3%), 
loneliness (91.3%), fear of re-infection (85.3%), 
economical problem (80 %), and stigma (66.7%) 
(Table 2). 
 
Table 2. Factors that contribute to the presence of 
anxiety and depression among COVID-19 
patients at Armed Force Comprehensive 
Hospital in Oromia, Ethiopia (n=150). 
 




Fear of death  Yes  145 96.7 
No  5 3.3 
Stigma  Yes  100 66.7 
No  50 33.3 
Poor sleep quality Yes  126 84 
No  24 16 
Fear of re-infection  Yes  128 85.3 
No  22 14.7 
Less family support  Yes  104 71.3 
No  46 30.7 
Loneliness  Yes  137 91.3 
No  13 8.7 
Economic problem  Yes  120 80 
No  30 20 
Lower oxygen 
saturation  
Yes  140 93.3 
No  10 6.7 
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The Prevalence of Depression and Anxiety among 
COVID-19 patients 
According to the multidimensional scoring 
system of Beck’s depression and anxiety Inventory 
measuring scales, the proportion of mild, 
borderline clinical, moderate, and severe 
depression was 7.3%, 18.7%, 56%, and 9.3%, 
respectively. Similarly, mild, moderate, and severe 
anxiety was 6%, 10%, and 76.7%, respectively. The 
overall prevalence of depression from borderline 
clinical to severe was 84% while that of anxiety 
from moderate to severe was 86.7%. 
 
Factors Associated with Depression and Anxiety 
of the COVID-19 patients  
In the bivariate analyses, sociodemographic 
factors (age, sex, and marital status), and factors 
for depression and anxiety level concerning COVID-
19 patients (fear of death, stigma, fear of re-
infection, loneliness, less family support, poor 
sleep quality, low oxygen saturation, and 
economic problem) had a statistically significant 
association with depression and anxiety level, 
while religion, educational status, and occupation 
did not have an association with depression and 
anxiety. However, in the multivariate logistic 
regression analysis, age, marital status, fear of 
death, fear of re-infection, loneliness, less family 
support, poor sleep quality, low oxygen saturation, 
and an economic problem had a statistically 
significant association with both depression and 
anxiety. 
Those who were married and divorced were 
more likely develop depression and anxiety than 
others (AOR=3.61; CI: 3.12, 3.74), AOR=2.60; CI: 1.56, 
4.36), (AOR =3.12; CI: 0.54, 3.34), and (AOR =1.60; CI: 
1.64, 3.68), respectively. Fear of death among 
depressed and anxious patients was (AOR =2.26; CI: 
1.30, 4.67) and (AOR =4.18; CI: 1.32, 5.33). Poor sleep 
quality was more likely affects depressed and 
anxious COVID-19 patients were (AOR =3.56; CI: 
1.50, 5.44) and (AOR =2.12; CI: 1.42, 3.59). Fear of re-
infection, less family support, loneliness and lower 
oxygen saturation among depressed and anxious 
patients were (AOR =3.61; CI: 2.21,5.87), (AOR =2.17; 
CI: 1.42, 3.38), (AOR =2.43; CI: 1.34,5.91), (AOR =3.11; 
CI: 1.32, 3.35), (AOR =4.01; CI: 2.33,8.77), (AOR =3.18; 
CI: 1.42, 3.39), (AOR =2.22; CI: 1.43,4.54), (AOR =4.10; 
CI: 1.42, 5.35), respectively positively associated 
(Table 3). 
 
Table 3. Factors Associated with Depression and Anxiety among COVID-19 patients at COVID-19 center of Armed 
Force Comprehensive Hospital Oromia, Ethiopia (n=150).  
 
Explanatory Variables                   Depression                         Anxiety  
COR, 95%CI AOR,95%CI COR,95%CI AOR,95%CI 
Age  18-22 1.00 1.00 1.00 1.00 
23-27 2.26(1.30,4.67) 2.19(1.42,3.39) 3.15(0.55,5.11) 2.11(.76,3.66) 
28-32 2.85(0.69,4.23) 3.14(0.54,3.34) 2.26(1.30,4.67) 1.19(1.12,3.30) * 
> 33 3.43(0.54,4.33) 4.72(0.34,5.76) 2.61(2.13,3.14) 2.11(1.35,3.77) * 
Sex  Male  1.00 1.00 1.00 1.00 
Female  8.11(1.94,13.93) 2.84(1.12,6.78) 2.24(1.42,4.52) 2.35(1.14,4.51) * 
Marital status  Single  1.00 1.00 1.00 1.00 
Married  0.43(0.41,0.87) 3.61(3.12,3.74) 0.76(0.56,1.92) 2.60(1.56,4.36) * 
Divorce  2.85(0.69,4.25) 3.12(0.54,3.34) 1.67(1.32,2.52) 1.60(1.64,3.68) * 
Fear of death Yes  5.26(1.50,9.76) 2.26(1.30,4.67) 2.08(1.02,4.24) 4.18(1.32,5.33) * 
No  1.00 1.00 1.00 1.00 
Poor sleep quality  Yes  0.66(0.01,5.67) 3.56(1.50,5.44) 1.15(1.12,2.69) 2.12(1.42,3.59) * 
No  1.00 1.00 1.00 1.00 
Fear of re-infected  Yes  1.43(1.22,7.23) 3.61(2.21,5.87) 1.43(0.62,3.13) 2.17(1.42,3.38) * 
No  1.00 1.00 1.00 1.00 
Less family support  Yes  1.11(1.01,3.54) 2.43(1.34,5.91) 1.23(0.76,3.25) 3.11(1.32,3.35) * 
No  1.00 1.00 1.00 1.00 
Loneliness Yes  4.17(0.26,8.12) 4.01(2.33,8.77) 2.21(0.41,4.46) 3.18(1.42,3.39) * 
No  1.00 1.00 1.00 1.00 
Economic problem  Yes  2.22(1.82,3.28) 1.92(1.68,3.78) 1.52(0.53,2.44) 2.13(1.43,3.38) * 
No  1.00 1.00 1.00 1.00 
Lower oxygen saturation  Yes  6.31(3.33,12.32) 2.22(1.43,4.54) 1.57(0.89,4.13) 4.10(1.42,5.35) * 
No  1.00 1.00 1.00 1.00 
*Refers to a significant association (p-value < 0.05) 
1.00 = reference  
AOR: Adjusted odds ratio  
COR: Crudes odds ratio 
CI: confidence interval 




In this study, we assessed the prevalence of 
depression and anxiety and their associated factors 
among COVID-19 patients at the Armed Force 
Comprehensive COVID-19 center Hospital in 
Oromia, Ethiopia. The age of respondents ranges 
from 18 to 60 years with the mean age of 29 ± 7.6 
years. Of the total participants, 84% had 
depression and 86.7% had anxiety. This high 
prevalence of depression and anxiety at the COVID-
19 center can exert an impact on the patient’s life 
or prognosis. Due attention is necessary because 
global health threats with devastating 
consequences of COVID-19 and the burden of 
depression and anxiety can potentially impact the 
outcome of this pandemic disease (Chinazzi et al., 
2020; Nishiura et al., 2020; Zhou et al., 2020).  
The prevalence of depression and anxiety were 
higher (84% depression and 86.7% anxiety) than 
the findings of the studies done in Huoshenshan 
Hospital, Wuhan China, (28.47% and 34.72%) and 
Jianghan Fangcang Shelter Hospital in Wuhan 
China 13.4% and 8.6 %, respectively (Dai et al., 
2020; Kong et al., 2020; Tariku, 2020). This might be 
because that study had been conducted in a 
different community with different socio-economic 
factors.  
Another finding of our present study identified 
that older age, being female, married, and 
divorced have a positive association with 
depression and anxiety which was similar to the 
study conducted in China, Italy, and Spain 
(Barzilay et al., 2020; Dai et al., 2020; González-
Sanguino et al., 2020; Kong et al., 2020; Rossi et al., 
2020; Sher, 2020; Wang et al., 2020). 
The result found in this study indicated that 
those respondents who had been fear of death 
were 2 times more likely to have depression and 4 
times more likely to have anxiety compared to 
those who had not been with fear of death. This 
finding was similar to the result of other studies 
(Barzilay et al., 2020; González-Sanguino et al., 
2020). This might be partly explained by the fact 
that fear of death causes a multidimensional effect 
on the psychology of respondents while they think 
more about the quarantine, loss of social support, 
and decreased family relationships. 
Those who had been known to be less family 
support were 2 times more likely to have 
depression and 3 times more likely to have anxiety 
compared to those who have good family support. 
On the other hand, even if it was not associated 
with both depression and anxiety, stigma might 
have a psychological scar that might be painful. 
Those who had poor sleep quality and fear of re-
infection had more likely 3 times depression and 2 
times anxiety compared to those who had no sleep 
problem and fear of re-infection. This study 
substantiates with the previous study conducted in 
other settings (Chang et al.; Dai et al., 2020; Sher, 
2020). The economic problem of the respondents, 
in general, had the possibility of altering the 
presence of depression and anxiety which 
corroborates with a previous study (Barzilay et al., 
2020; Brooks et al., 2020; Sher, 2020). Another 
finding from the present study was loneliness and 
low oxygen saturation of COVID-19 patients who 
were more likely to have depression and anxiety 
symptoms. COVID-19 had a significant impact on 
people's health, economy, sleep, fear, and 
relationship (Barzilay et al., 2020; Brooks et al., 
2020; Dai et al., 2020; Endomba, Wouna, & 
Danwang, 2020; González-Sanguino et al., 2020; 
Guo et al., 2020; Hirvonen, Abate, & de Brauw, 
2020; Huang & Zhao, 2020; Ma et al., 2020) our 
study of why the prevalence of depression and 
anxiety is high among COVID-19 patients. This is 
the first study conducted in Ethiopia to assess 
depression and anxiety at the COVID-19 center of 
Armed Force Comprehensive Hospital in Ethiopia. 
However, the study design itself has limitations 






There is a high reaction feeling of depression and 
anxiety among COVID-19 patients. Factors 
associated with depression and anxiety among 
COVID-19 patients were fear of death, loneliness, 
lower oxygen saturation, and lack of social 
support. Efforts need to be focused to raise 
awareness of how depression and anxiety exert an 
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